Quick Search:       Advanced Search
Chinese Version 
Online office
Journal Online
Download
Top
Links

扫描微信二维码,获取更多信息
Influence of TCM therapy for supplementing Pi (脾) and nourishing Shen (肾) on dendritic cell function in patients with chronic hepatitis B treated by lamivudine
  
View Full Text  View/Add Comment  Download reader
KeyWord:TCM therapy for supplementing Pi and nourishing Shen  lamivudine  chronic hepatitis B  dendritic cells
Author NameAffiliationE-mail
Yong-hua Zhang Department of Hepatopathy, Zhejiang Hospital of Integrated Traditional and Western Medicine, Hangzhou, 310000, China  
Yi-hui Liu Department of Hepatopathy, Zhejiang Hospital of Integrated Traditional and Western Medicine, Hangzhou, 310000, China huizai111@163.com 
Hits: 1254
Download times: 472
Abstract:
      Objective  To observe the influence of traditional Chinese medicine (TCM) therapy for supplementing Pi (脾) and nourishing Shen (肾, SPNS) on dendritic cell function in patients with chronic hepatitis B (CHB) treated by lamivudine. Methods  Sixty CHB patients with positive HBeAg were equally randomized by digital table into two groups: the observation group and the control group. Patients in the control group were treated with lamivudine only, while patients in the observation group were treated with lamivudine combined with SPNS fomula, for 12 weeks. The phenotype and function of dendritic cell, as well as its secretion factor interleukin 12 (IL-12) in all patients were determined after termination of therapy and the impacts on alanine transaminase (ALT) and HBVDNA were observed. Results  The phenotypes of dendritic cells such as CD1a, CD80, CD86, human leukocyte antigen (HLA-DR) and intercellular adhesion molecule-1, as well as the levels of stimulation index (SI) and IL-12 were higher in the observation group than those in the control group (P<0.05 or P<0.01). Meanwhile, signififi cant difference between the two groups was also shown in the normalizing rates of ALT and HBV-DNA (P<0.05). Conclusion  TCM therapy for SPNS can signifificantly improve the function of dendritic cells in patients with CHB treated by lamivudine and enhance the early stage response of patients to the treatment. Supported by General Scientific Research Development Projects of Science and Technology Department of Zhejiang Province (No. 2006C33007)
Close